Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.

Hiraoka M, Ishikura S

Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho, Sakyo-ku, Kyoto, Japan. hiraok@kuhp.kyoto-u.ac.jp

Stereotactic body radiation therapy (SBRT) is a new treatment modality. To confirm the safety and efficacy, the Radiation Therapy Study Group of the Japan Clinical Oncology Group (JCOG) has started a phase II study of SBRT for stage IA non-small cell lung cancer (JCOG 0403). This study is ongoing with a strict quality control and quality assurance program, and the results will indicate whether a future phase III trial comparing SBRT with surgery is warranted. In addition, international collaboration will be critical to establish the role of SBRT in the treatment of lung cancer.

Published 2 July 2007 in J Thorac Oncol, 2(7): S115-7.
Full-text of this article is available online (may require subscription).

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.